Form D · Biotechnology
CHIASMA, INC
Newton Centre, MA · CIK 0001339469
Offering snapshot reported Mar 5, 2015 · SEC filing
- Reported sold
- $69.7M Offering amount: $87.2M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 16, 2014 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$33,774,763 → $69,722,786
- Reported investors11 → 21
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 5, 2015 | Amendment | $69,722,786 | $35,948,023vs Dec 24, 2014 | 21 | SEC filing |
| Dec 24, 2014 | Initial | $33,774,763 | No comparison | 11 | SEC filing |
| Jul 23, 2012 | Initial | $10,026,669 | No comparison | 10 | SEC filing |
| Jun 7, 2012 | Initial | $3,038,335 | No comparison | 8 | SEC filing |
| Jul 1, 2011 | Initial | $5,115,000 | No comparison | 10 | SEC filing |
| Jun 14, 2011 | Amendment | $10,000,000 | $8,000,000vs Jul 22, 2010 | 8 | SEC filing |
| Mar 9, 2011 | Amendment | $9,000,000 | $4,000,000vs Jan 6, 2011 | 7 | SEC filing |
| Jan 6, 2011 | Amendment | $5,000,000 | $3,000,000vs Jul 22, 2010 | 7 | SEC filing |
| Jul 22, 2010 | Initial | $2,000,000 | No comparison | 7 | SEC filing |
| Nov 24, 2009 | Initial | $2,800,000 | No comparison | 6 | SEC filing |
| May 21, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 2, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 8, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 21, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-230889
The offering amount includes the aggregate value of un-exercised warrants to purchase common stock that were a part of the offering.
Source: Form D, filed Mar 5, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dror Brandwein | Director |
| Robert Citron | Executive |
| Todd T. Foley | Director |
| Ansbert K. Gadicke | Director |
| Bard J. Geesaman | Director |
| Roni Mamluk | Director, Executive |
| Dalia Megiddo | Director |
| Vincent Miles | Director |
| Scott Minick | Director |
| Chaime Orlev | Executive |
| Fredric D. Price | Director, Executive |
| John A. Scarlett | Director |
| Benjamin T. Sporn | Executive |
| David M. Stack | Director |
| Sam Teichman | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
831 Beacon Street Suite 313
Newton Centre, MA, 02459
Newton Centre, MA, 02459